FINWIRES · TerminalLIVE
FINWIRES

RBC Downgrades ResMed to Sector Perform From Outperform, Cuts Price Target to $234 From $276

By

ResMed (RMD) has an average rating of overweight and mean price target of $266.02, according to analysts polled by FactSet.

What else is happening in Research?